Showing 381 - 400 of 584 results.
The type of psychosocial service a person with cancer is referred to as part of their cancer treatment or follow-up,...
The eviQ protocol identifier for the systemic therapy agent protocol administered during the course of treatment for cancer.
The location of cancer cells invasion into the lymphatic and/or vascular spaces for a person with cancer of the corpus...
Age-standardised mortality rate by major cause of death, and rate ratios for Indigenous people and people living in remote or...
The most valid basis of diagnosis of the first recurrence of locoregional cancer or distant metastasis in a person with...
The type of tumour that remains after the course of cancer treatment, as represented by a code.
The reason(s) that second-line treatment, treatment that was not part of the planned initial course of treatment, was administered to...
The type of radiotherapy administered during the course of treatment for cancer, as represented by a code.
The histopathological grade or differentiation in a person with cancer, as represented by a code.
The result of oestrogen receptor assay at the time of diagnosis of the primary breast tumour, as represented by a...
The type of radiotherapy administered during the initial course of treatment for cancer, as represented by a code.
The total number of radiotherapy sessions (fractions) administered during the course of treatment for cancer.
The reason(s) a person with cancer was not administered treatment for cancer, as represented by a code.
Describes the type of immunohistochemistry stains used to assist in the identification of abnormal cells and hence the diagnosis of...
The anatomical extent of disease at diagnosis based on the previously coded T,N and M stage categories, as represented by...
The total number of regional lymph nodes examined by a pathologist and reported as containing tumour.
The results of progesterone receptor assay at the time or diagnosis of the primary breast tumour, as represented by a...
Whether a person with a solid tumour has received neoadjuvant therapy, as represented by a code.
The target site of radiotherapy administered during the course of treatment for cancer, as represented by a code.